Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Galapagos reaches milestone in immuno-inflammation alliance with GSK
Galapagos CEO Onno van de Stolpe said the company has identified five candidate drugs of which two have been in-licensed by GSK to date, since the start of
Galapagos CEO Onno van de Stolpe said the company has identified five candidate drugs of which two have been in-licensed by GSK to date, since the start of
ARGAMATE Granule is indicated for the treatment of hyperkalemia resulting from acute or chronic renal failure and it helps in withdrawing the unnecessary potassium in the gastrointestinal tract.
Aureus is involved in gathering high quality quantitative biological activity data of major therapeutic drugs, which enables researchers to identify the promising compounds, repurpose existing compounds as well
HyCryo media, a serum-free, animal component-free product, is intended for cryogenic preservation and storage of standard cell lines, while HyCryo-STEM, which is designed for stem cell applications, enhances
The ADC facility expansion is expected to double the present large-scale manufacturing capacity in Visp without interrupting the current operations. Lonza chemical manufacturing business unit head Stefan Stoffel
The research partnership will leverage first rate science performed at Yale University along with Evotec’s drug discovery infrastructure and knowledge. Evotec chief scientific officer Dr Cord Dohrmann said,
Grayling is involved in manufacturing various brands for the asbestos abatement and remediation industry including Avail glove bags, D-Con decontamination enclosures, and Control chemicals. The acquisition is expected
The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field and global rights to develop and commercialize LNA drugs targeting six additional microRNAs. Santaris
Developed by Affymax, the FDA-approved OMONTYS is a synthetic, pegylated erythropoiesis-stimulating agent (ESA) that is peptide-based and its building blocks (amino acids) are arranged in a different order
Takeda Canada and Paladin will co-promote the allergy vaccine product indicated for the treatment of allergic rhinitis due to ragweed pollen for the first eight months prior to